Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
127
天
Real-world experience with posttransplant maintenance therapy in patients with myeloid neoplasms with active disease before allogeneic hematopoietic cell transplantation
作者
Hüseyin Sakiz; Raphael Battegay; Beatrice Drexler; Darius Juskevicius; Sabine Gerull; Michele Hoffmann; Roby Mathew; Francesca Matteazzi; Lucas Simeon; Georg Stussi; Jakob R. Passweg; Joerg P. Halter展开收起
作者单位
1. Department of Hematology, University Hospital Basel, Basel, Switzerland; 2. Department of Hematology, Cantonal Hospital Aarau, Aarau, Switzerland; 3. Department of Medical Oncology, Inselspital, University Hospital of Bern, Bern, Switzerland; 4. Department of Hematology, Luzerner Kantonsspital, Lucerne, Switzerland; 5. Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland展开收起
154
天
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation
作者
Takuto Mori; Nobuhiro Hiramoto; Yoshimitsu Shimomura; Masao Ogata; Kaito Harada; Naoyuki Uchida; Masatsugu Tanaka; Makoto Onizuka; Masahito Tokunaga; Atsushi Wake; Yasufumi Uehara; Toshimitsu Ueki; Masashi Sawa; Satoshi Takahashi; Mamiko Sakata-Yanagimoto; Keisuke Kataoka; Toshiro Kawakita; Noriko Doki; Fumihiko Ishimaru; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Hideki Nakasone; Kimikazu Yakushijin展开收起
作者单位
1. Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan; 2. Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 3. Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan; 4. Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Japan; 5. Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan; 6. Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan; 7. Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan; 8. Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; 9. Department of Hematology, Imamura General Hospital, Kagoshima, Japan; 10. Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Kawasaki, Japan; 11. Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan; 12. Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan; 13. Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan; 14. Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 15. Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; 16. Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; 17. Department of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan; 18. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; 19. Japanese Red Cross Blood Service Headquarters, Tokyo, Japan; 20. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; 21. Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; 22. Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; 23. Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan; 24. Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; 25. Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan展开收起
117
天
Use of an unrelated cord blood unit as an emergency rescue graft after last-minute donor collection cancellation
作者
Irene Donnini; Sergio Querol; Nerea Castillo; Simona Pollichieni; Chiara Nozzoli; Alejandra Martínez-Trillos; Mónica Linares; Michela Santosuosso; Serena Urbani; Jesús Fernández-Sojo; Nicoletta Sacchi展开收起
作者单位
1. Cell Therapy and Transfusion Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; 2. Spanish Bone Marrow Donor Registry (REDMO), Josep Carreras Leukaemia Foundation, Barcelona, Spain; 3. Cell Therapy Service and Barcelona Cord Blood Bank, Banc de Sang i Teixits, Barcelona, Spain; 4. Italian Bone Marrow Donor Registry (IBMDR), Diagnostic and Therapeutic Services Department, E.O. Ospedali Galliera, Genoa, Italy; 5. Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy展开收起
24
天
33
天
From salvage therapy to survivorship: mapping the late effects of autologous stem cell transplantation in autoimmune disease
作者
Santhosh Thyagu; Piyanuch Kongtim展开收起
作者单位
1. Transplantation and Cellular Therapy Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Canada; 2. Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, USA展开收起
177
天
Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis
作者
Xueyao Li; Wenhao Wang; Ruixin Li; Jieya Luo; Xin Chen; Weihua Zhai; Rongli Zhang; Jialin Wei; Donglin Yang; Yi He; Aiming Pang; Sizhou Feng; Mingzhe Han; Yigeng Cao; Erlie Jiang展开收起
作者单位
1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China; 2. Tianjin Institutes of Health Science, Tianjin, China; 3. Haihe Laboratory of Cell Ecosystem, Tianjin Medical University, Tianjin, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天